Based on these reports, we hypothesized that the inhibitory effect of SLPI on E6 positive HNSCC progression was partly achieved through preventing the activation of NF-κB caused by E6 oncogene. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.